STARBRIGHT
LIVE

Serial Number

97649648

Owner

BIO-RAD LABORATORIES, INC.

Attorney

Margaret C. McHugh

Filing Date

Oct 26, 2022

Add to watchlist:

No watchlists yet
View on USPTO

STARBRIGHT Trademark

Serial Number: 97649648 • Registration: 8096300

STARBRIGHT is a trademark filed by BIO-RAD LABORATORIES, INC. on October 26, 2022. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

BIO-RAD LABORATORIES, INC. (237 trademarks)

HERCULES, CA 94547

Entity Type: 03

Trademark Details

Filing Date

October 26, 2022

Registration Date

January 6, 2026

Published for Opposition

October 31, 2023

Goods & Services

Fluorescent dyes for scientific or research use; fluorescent dyes for scientific use in life science applications; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for scientific, laboratory, or research purposes; fluorescent dyes for research use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; proteins for scientific and research use; cell culture proteins for scientific and research use; biochemical, namely, monoclonal antibodies for in vitro scientific and research use; biochemically labelled and enzyme labelled antibodies for use in science; microparticles containing fluorescent dyes for flow cytometry and scientific use; enzyme and chemical labelling molecules for use in science; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; assays and reagents for use in scientific, laboratory and research purposes; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; Chemical reagent for research purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules; Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for use in science; reagents in kit form for performing assays for scientific and research use; flow cytometry kits comprised of research reagents, buffers and controls for research laboratory use

Chemical analysis and research for others; medical laboratory services; medical testing for medical, scientific and research purposes; research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services

Fluorescent dyes and chemicals for medical use; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for medical purposes; proteins for medical use; cell culture proteins for medical use; monoclonal antibodies for medical use; monoclonal antibodies for in vitro medical use; fluorescent dyes for medical use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; biochemically labelled and enzyme labelled antibodies for medical use; microparticles containing fluorescent dyes for flow cytometry and medical use; chemical and biochemical preparations, assays, dyes, and reagents for clinical and medical laboratory use; chemical reagents for medical purposes for flow cytometry; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical purposes; Chemical reagent for medical purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules. chemicals and chemical reagents for medical use; reagents in kit form for performing assays for medical purposes; chemicals agents for use in separation for medical use; cell culture media for use in separation techniques for medical use; biochemical test kits comprising assays and reagents for medical purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for medical purposes; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for medical purposes; flow cytometry kits comprised of research reagents, buffers and controls for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 6, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 6, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Dec 13, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 13, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 12, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 12, 2025 ERFR
ASSIGNED TO EXAMINER
Nov 6, 2025 DOCK
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 12, 2025 GNFN
FINAL REFUSAL E-MAILED
Sep 12, 2025 GNFR
SU - FINAL REFUSAL - WRITTEN
Sep 12, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 2, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 2, 2025 CRFA
ASSIGNED TO LIE
Sep 2, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jul 29, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jul 29, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 14, 2025 SUPC
USE AMENDMENT FILED
Jun 26, 2025 IUAF
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 26, 2025 EXRA
TEAS STATEMENT OF USE RECEIVED
Jun 26, 2025 EISU
SOU EXTENSION 3 GRANTED
Jun 26, 2025 EX3G
SOU EXTENSION 3 FILED
Jun 26, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Jun 26, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 29, 2025 EXRA
SOU EXTENSION 2 GRANTED
Jan 29, 2025 EX2G
SOU EXTENSION 2 FILED
Dec 26, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 26, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 29, 2024 EXRA
SOU EXTENSION 1 GRANTED
Aug 29, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 26, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Jul 3, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Jul 3, 2024 NREV
PETITION TO REVIVE-GRANTED
Jul 3, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Jul 3, 2024 PROA
SOU EXTENSION 1 FILED
Jun 26, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 26, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 31, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 31, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 11, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 25, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 25, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 25, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 25, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 25, 2023 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 14, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 5, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 22, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 8, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 7, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 7, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 7, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jul 7, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jul 7, 2023 CNRT
ASSIGNED TO EXAMINER
Jul 3, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2022 NWOS
NEW APPLICATION ENTERED
Oct 29, 2022 NWAP